By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom announced after the close of the market on Wednesday that it has completed its public offering of 14.95 million shares of its common stock at $4.15 per share, raising about $62 million in gross proceeds.

The number of shares includes 1.95 million shares sold pursuant to the full exercise of an over-allotment option granted to its underwriters. Jefferies acted as sole book-running manager for the offering. Oppenheimer and William Blair were co-managers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.